Life ScienceCompany
Who owns ImmPACT Bio?
ImmPACT Bio is owned by Lyell Immunopharma. It was acquired in 2024.
ImmPACT Bio is owned by Lyell Immunopharma. It was acquired in 2024.
8501 Fallbrook Avenue, Suite 200,
West Hills, California
91304
United States,
(818) 857-4828
www.immpact-bio.com
| Status | Dates | Investor(s) | |
|---|---|---|---|
| Investment | Exit | ||
| Current | 2024-10-24 | Lyell | |
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.